Berodual



Combined with:

Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 20.6%
Chronic Obstructive Pulmonary Disease 10.4%
Hypertension 8.9%
Psoas Abscess 7.0%
Pain 5.7%
Thrombosis Prophylaxis 5.7%
Supraventricular Tachycardia 5.2%
Epilepsy 5.0%
Supplementation Therapy 4.5%
Dermatitis 4.4%
Rash 3.9%
Grand Mal Convulsion 2.9%
Tachycardia Paroxysmal 2.6%
Hyperglycaemia 2.4%
Essential Hypertension 2.1%
Fluid Replacement 1.9%
Nausea 1.9%
Restlessness 1.8%
Conjunctivitis 1.6%
Sleep Disorder 1.6%
Toxic Epidermal Necrolysis 22.9%
Iron Deficiency Anaemia 14.6%
Stevens-johnson Syndrome 12.5%
Abdominal Pain Upper 4.2%
Pneumonia 4.2%
Right Ventricular Failure 4.2%
Somnolence 4.2%
Speech Disorder 4.2%
Vision Blurred 4.2%
Wheezing 4.2%
Chronic Obstructive Pulmonary Disease 2.1%
Gastric Ulcer 2.1%
Lung Neoplasm Malignant 2.1%
Maternal Drugs Affecting Foetus 2.1%
Maternal Exposure During Pregnancy 2.1%
Polydactyly 2.1%
Rhinorrhoea 2.1%
Rib Fracture 2.1%
Stomatitis 2.1%
Suicide Attempt 2.1%
Concomitant
Product Used For Unknown Indication 24.6%
Chronic Obstructive Pulmonary Disease 11.8%
Drug Use For Unknown Indication 9.9%
Asthma 6.9%
Hypertension 5.9%
Non-small Cell Lung Cancer 5.9%
Prophylaxis 5.0%
Dementia Alzheimer's Type 4.9%
Depression 4.2%
Pain 3.3%
Osteoporosis 2.8%
Rheumatoid Arthritis 1.9%
Type 2 Diabetes Mellitus 1.9%
Thrombosis Prophylaxis 1.9%
Head And Neck Cancer 1.8%
Anaemia 1.5%
Bronchopneumonia 1.5%
Diabetes Mellitus 1.5%
Acute Coronary Syndrome 1.4%
Granulocytopenia 1.4%
Thrombocytopenia 8.2%
Dyspnoea 7.5%
Vomiting 7.5%
Urticaria 6.9%
Somnolence 6.3%
Asthma 5.0%
Death 5.0%
Pneumonia 5.0%
Weight Decreased 5.0%
Granulocytopenia 4.4%
Iron Deficiency Anaemia 4.4%
Pruritus 4.4%
Toxic Epidermal Necrolysis 4.4%
Vascular Pseudoaneurysm 4.4%
Chronic Obstructive Pulmonary Disease 3.8%
Respiratory Failure 3.8%
Tachycardia 3.8%
Weight Increased 3.8%
Drug Ineffective 3.1%
Lung Disorder 3.1%